Drug intelligence / Profile preview

valproate + creatine

Development stage
Phase 2
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

This is a combination of two agents, valproate (also known as valproic acid or sodium valproate) and creatine. Valproate is an anticonvulsant and mood stabilizer primarily used for the treatment of epilepsy, bipolar disorder, and migraine prophylaxis. Its mechanism involves increasing brain concentrations of gamma-aminobutyric acid (GABA), thereby exerting inhibitory effects on neuronal firing. Creatine is a naturally occurring compound involved in cellular energy metabolism, commonly used as a dietary supplement to enhance muscle performance and support neurological function. There are no approved pharmaceutical products combining these two agents; however, their interaction has been studied due to potential metabolic effects—valproate can disrupt creatine metabolism in the brain by causing hyperammonemia or through inhibition of enzymes involved in creatine synthesis and transport[1][2]. This may result in abnormal urinary excretion profiles for creatine metabolites.

02

Targets

HDAC (HDAC family)GABA-B (Gamma-aminobutyric acid receptor type B)

Beyond the preview

Go deeper on valproate + creatine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on valproate + creatine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call